Literature DB >> 21629219

Prostate cancer: searching for bone metastases--how, when and why?

Fred Saad.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21629219     DOI： 10.1038/nrurol.2011.70

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  NCCN clinical practice guidelines in oncology: prostate cancer.

Authors:  James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

2.  Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.

Authors:  Fred Saad; James Eastham
Journal:  Urology       Date:  2010-11       Impact factor: 2.649

3.  Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Authors:  Matthew R Smith; Fairooz Kabbinavar; Fred Saad; Arif Hussain; Marc C Gittelman; David L Bilhartz; Chris Wynne; Robin Murray; Norman R Zinner; Claude Schulman; Ronald Linnartz; Ming Zheng; Carsten Goessl; Yong-Jiang Hei; Eric J Small; Richard Cook; Celestia S Higano
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

Review 4.  Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer.

Authors:  Fred Saad; James A Eastham; Matthew R Smith
Journal:  Urol Oncol       Date:  2010-12-16       Impact factor: 3.498

5.  Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.

Authors:  C McArthur; G McLaughlin; R N Meddings
Journal:  Br J Radiol       Date:  2011-02-08       Impact factor: 3.039

6.  Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer.

Authors:  Matthew R Smith; Richard Cook; Ker-Ai Lee; Joel B Nelson
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

7.  Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

Authors:  Frédéric E Lecouvet; Daphné Geukens; Annabelle Stainier; François Jamar; Jacques Jamart; Bertrand Janne d'Othée; Patrick Therasse; Bruno Vande Berg; Bertrand Tombal
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

Review 8.  Consensus on the utility of bone markers in the malignant bone disease setting.

Authors:  Robert Coleman; Luis Costa; Fred Saad; Richard Cook; Peyman Hadji; Evangelos Terpos; Patrick Garnero; Janet Brown; Jean-Jacques Body; Matthew Smith; Ker-Ai Lee; Pierre Major; Meletios Dimopoulos; Allan Lipton
Journal:  Crit Rev Oncol Hematol       Date:  2011-03-15       Impact factor: 6.312
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.